PD Dr. Özgür Yaldizli


Research Areas

 

The aim of this research group is to explore and validate new MRI biomarkers in multiple sclerosis and related neuroimmunological diseases such as neuromyelitis optica spectrum disorder or myelin oligodendrocyte glycoprotein associated diseases.

To reach this goal, we work on MRI data acquired within the Swiss MS cohort study and collaborate with other work groups and international research institutions such as University College London, the Charité Universitätsmedizin Berlin, CHUV Lausanne and Kyushu University in Fukuoka, Japan

think
PD Dr. Özgür Yaldizli

Principal Investigator
University Hospital Basel
Petersgraben 4
4031 Basel
Switzerland